|
|
||||||||
1 From the Department of Ophthalmology, Cornea and Immunology Unit, Hospital Geral de Santo António, Porto, Portugal; the 2 Department of Ophthalmology, Instituto de Ciências Biomédicas Abel Salazar, University of Porto, Portugal; the 3 Department of Ophthalmo-Immunology, Netherlands Ophthalmic Research Institute, Amsterdam, the Netherlands; the 4 Department of Cell Biology, Free University, Amsterdam, the Netherlands; and the 5 Department of Ophthalmology, University of Amsterdam.
PURPOSE. Corneal allograft rejection in rats can be prevented by subconjunctival injections of liposomes containing dichloromethylene diphosphonate (clodronateLIP), which selectively eliminate macrophages. In this study, the effect of clodronateLIP treatment on cytokine mRNA levels in corneal allografts was examined.
METHODS. AO rats received corneal grafts of PVG rats. Rats were either
not treated or injected subconjunctivally with clodronateLIP on the
day of transplantation and on postoperative days (PODs) 2, 4, 6, and 8.
RNA was isolated from the graft and rim of corneas at different times
after transplantation and from normal controls. Interleukin (IL)-1ß,
IL-1 receptor antagonist (IL-1RA), IL-2, IL-4, IL-6, IL-10, IL-12p40,
tumor necrosis factor (TNF)-
, TNF-ß/lymphotoxin (LT), interferon
(IFN)-
, monocyte chemotactic protein 1 (MCP-1), and macrophage
inflammatory protein 2 (MIP-2) mRNA levels were analyzed by
semiquantitative reverse transcriptionpolymerase chain reaction
(RTPCR).
RESULTS. Corneal rejection, observed in all untreated rats by POD 12, was
associated with increased mRNA levels of all cytokines investigated in
grafts and rims. ClodronateLIP treatment prevented allograft
rejection and strongly decreased the levels of IL-1ß, IL-1RA, IL-2,
IL-4, IL-6, IL-10, IFN-
, TNF-ß/LT, MCP-1, and MIP-2 mRNA in grafts
and IL-1 ß, IL-2, IL-4, IL-6, and IFN-
mRNA in rims.
Interleukin-12p40 mRNA levels were unaltered in clodronate-treated
rats, except for a transient increase in grafts at POD 3. TNF-
mRNA
levels were increased by clodronateLIP in grafts and rims early after
transplantation (PODs 3 and 7). Despite a normal appearance, long-term
accepted corneal grafts (POD 100) contained mRNA for IL-10, IL-12p40,
TNF-
, MCP-1, and MIP-2.
CONCLUSIONS. Clodronate-liposome treatment markedly altered the mRNA levels of all cytokines investigated in corneal allografts. These results may explain in part the mechanism by which clodronateLIP treatment prevents corneal allograft rejection.
This article has been cited by other articles:
![]() |
S. Klebe, D. J. Coster, P. J. Sykes, S. Swinburne, P. Hallsworth, J.-P. Y. Scheerlinck, R. Krishnan, and K. A. Williams Prolongation of Sheep Corneal Allograft Survival by Transfer of the Gene Encoding Ovine IL-12-p40 but Not IL-4 to Donor Corneal Endothelium J. Immunol., August 15, 2005; 175(4): 2219 - 2226. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Yamada, K. Maruyama, Y. Sano, S. Kinoshita, Y. Murata, and J. Hamuro Promotion of Corneal Allograft Survival by the Induction of Oxidative Macrophages Invest. Ophthalmol. Vis. Sci., February 1, 2004; 45(2): 448 - 454. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Banerjee Liposomes: Applications in Medicine J Biomater Appl, July 1, 2001; 16(1): 3 - 21. [Abstract] [PDF] |
||||
![]() |
Y. Sekine, K. Yasufuku, K. M. Heidler, O. W. Cummings, N. Van Rooijen, T. Fujisawa, J. Brown, and D. S. Wilkes Monocyte Chemoattractant Protein-1 and RANTES Are Chemotactic for Graft Infiltrating Lymphocytes during Acute Lung Allograft Rejection Am. J. Respir. Cell Mol. Biol., December 1, 2000; 23(6): 719 - 726. [Abstract] [Full Text] |
||||
![]() |
T. P. A. M. Slegers, P. F. Torres, L. Broersma, N. van Rooijen, G. van Rij, and R. van der Gaag Effect of Macrophage Depletion on Immune Effector Mechanisms during Corneal Allograft Rejection in Rats Invest. Ophthalmol. Vis. Sci., July 1, 2000; 41(8): 2239 - 2247. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |